2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow DDY391: new trials by email Literature Review of DDY391 trials Research Report on DDY391
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis DDY391, Placebo - Moderate to Severe Psoriatic Arthritis | Phase 2 | Recruiting | Novartis Pharmaceuticals | 220 | 2026-10-14 | 2026-10-13 |
| A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease DDY391, Placebo - Sjögren's Disease | Phase 2 | Recruiting | Novartis Pharmaceuticals | 344 | 2026-08-24 | 2026-10-28 |
Arthritis, Psoriatic (1) · Psoriasis (1) · Sjogren's Syndrome (1)
United States (2) · Australia (1) · Canada (1) · China (1) · Colombia (1) · Israel (1)
2025 (2)